TY - JOUR
T1 - Possible antidotes for suicide risk
T2 - What should we tell our patients?
AU - Bordelon, Sean
AU - Dinwiddie, Stephen H.
N1 - Publisher Copyright:
© SLACK Incorporated.
PY - 2017/9
Y1 - 2017/9
N2 - Suicidal behaviors and communications are obvious concerns for psychiatrists. Whereas the infrequency of completed suicide makes it hard to study and the alternative construct of “suicidality” is not uniformly defined across studies, associations can be found between treatments in the psychiatrist’s toolbox and possible suicide-protective effects. This review identifies several candidate treatments-psychotherapy, antidepressants, lithium, anticonvulsant agents, electroconvulsive therapy, and clozapine-and weighs their potential suicide-protective effects against their known risks.
AB - Suicidal behaviors and communications are obvious concerns for psychiatrists. Whereas the infrequency of completed suicide makes it hard to study and the alternative construct of “suicidality” is not uniformly defined across studies, associations can be found between treatments in the psychiatrist’s toolbox and possible suicide-protective effects. This review identifies several candidate treatments-psychotherapy, antidepressants, lithium, anticonvulsant agents, electroconvulsive therapy, and clozapine-and weighs their potential suicide-protective effects against their known risks.
UR - http://www.scopus.com/inward/record.url?scp=85029348611&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029348611&partnerID=8YFLogxK
U2 - 10.3928/00485713-20170803-01
DO - 10.3928/00485713-20170803-01
M3 - Article
AN - SCOPUS:85029348611
VL - 47
SP - 466
EP - 470
JO - Psychiatric Annals
JF - Psychiatric Annals
SN - 0048-5713
IS - 9
ER -
